For the Inventor, By the Inventor

Enter assignee name

Xiamen Innovax Biotech Co., Ltd.

USPTO Granted Patents = 23

CIPO Patents = 1

EPO Patents = 8

Forward Citations = 13

Loading Chart...

Loading Chart...

48 inventors (with patents filed for the assignee):

Ningshao Xia (23 out of 54 patents)

Shaowei Li (15 out of 26 patents)

Jun Zhang (13 out of 109 patents)

4. Ying Gu (8 out of 16 patents)

5. Minxi Wei (4 out of 6 patents)

6. Shengxiang Ge (4 out of 13 patents)

7. Wenxin Luo (4 out of 10 patents)

8. Chunyan Yang (4 out of 6 patents)

9. Huirong Pan (4 out of 7 patents)

10. Daning Wang (4 out of 4 patents)

11. Tingdong Li (3 out of 4 patents)

12. Shuo Song (3 out of 3 patents)

13. Maozhou He (3 out of 3 patents)

14. Zhihai Li (3 out of 3 patents)

15. Cuiling Song (3 out of 3 patents)

23 patents: Sort by Forward Citations

1. 12472250 - Preparation of zinc zoledronate micro-nanoparticle adjuvant and use thereof as vaccine adjuvant (2025-11-18),

2. 12419951 - Preparation of zinc risedronate micro/nano adjuvant and use thereof as vaccine adjuvant (2025-09-23),

3. 12097251 - Human papilloma virus type 51 L1 protein mutants (2024-09-24),

4. 11771754 - Mutant of L1 protein of human papillomavirus type 18 (2023-10-03),

5. 11464846 - Mutant of L1 protein of human papillomavirus type 66 (2022-10-11),

6. 11427618 - Mutant of L1 protein of human papillomavirus type 39 (2022-08-30),

7. 11339194 - Truncated rotavirus VP4 protein and application thereof (2022-05-24),

8. 11213580 - Mutant of L1 protein of human papillomavirus type 16 (2022-01-04),

9. 10940194 - Mutant of L1 protein of human papillomavirus type 58 (2021-03-09),

10. 10723767 - Truncated rotavirus VP4 protein and application thereof (2020-07-28),

11. 10537629 - Truncated L1 protein of human papillomavirus type 11 (2020-01-21),

12. 10513541 - Mutant of L1 protein of human papillomavirus type 11 (2019-12-24),

13. 9952217 - Anti-HBc quantitative detection method and uses thereof in monitoring and controlling disease progression of chronic hepatitis B patient and in predicting therapeutic effect (2018-04-24),

14. 9862933 - Method for in-vitro preparation of double-layered virus-like particles of rotavirus (2018-01-09),

15. 9856313 - Epitope of RSV fusion protein and antibody recognizing the same (2018-01-02),

Xiamen Innovax Biotech Co., Ltd. is a leading biotechnology company specializing in the research, development, and manufacturing of innovative vaccines. With a focus on preventing infectious diseases, Innovax Bio is committed to improving global public health. Our state-of-the-art facilities and dedicated team ensure the highest quality standards in vaccine production. We work closely with international partners and regulatory authorities to bring life-saving vaccines to the global market efficiently and safely.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

23 Patents

#24 in Xiamen

#1,155 in China

#26,820 in the World

Xiamen Innovax Biotech Co., Ltd.

Forward Citations = 13

48 inventors:

Ningshao Xia (23 out of 54 patents)

Shaowei Li (15 out of 26 patents)

Jun Zhang (13 out of 109 patents)

4. Ying Gu (8 out of 16 patents)

5. Minxi Wei (4 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…